Allgens Medical Technology CO., LTD. (688613.SS)
CNY 15.9
(1.08%)
CNY 15.9
(1.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 48.99 Million CNY | -49.09% |
| 2022 | 96.31 Million CNY | -28.61% |
| 2021 | 134.91 Million CNY | 32.02% |
| 2020 | 102.18 Million CNY | 37.26% |
| 2019 | 74.44 Million CNY | 113.93% |
| 2018 | 34.79 Million CNY | 26.69% |
| 2017 | 27.46 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -7.73 Million CNY | -486.19% |
| 2024 Q3 | -4.15 Million CNY | 134.33% |
| 2024 Q1 | 2 Million CNY | 137.96% |
| 2023 Q4 | -5.27 Million CNY | -129.08% |
| 2023 Q2 | 16.97 Million CNY | -11.6% |
| 2023 Q1 | 19.2 Million CNY | -29.42% |
| 2023 FY | 49.03 Million CNY | -49.09% |
| 2023 Q3 | 18.14 Million CNY | 6.88% |
| 2022 Q1 | -190.81 Thousand CNY | -100.51% |
| 2022 Q2 | 30.8 Million CNY | 16245.72% |
| 2022 FY | 96.31 Million CNY | -28.61% |
| 2022 Q4 | 27.2 Million CNY | -22.29% |
| 2022 Q3 | 35 Million CNY | 13.62% |
| 2021 FY | 134.91 Million CNY | 32.02% |
| 2021 Q2 | 36.26 Million CNY | 83.71% |
| 2021 Q1 | 19.74 Million CNY | -60.1% |
| 2021 Q4 | 37.3 Million CNY | -10.33% |
| 2021 Q3 | 41.6 Million CNY | 14.72% |
| 2020 FY | 102.18 Million CNY | 37.26% |
| 2020 Q1 | -192.51 Thousand CNY | -100.76% |
| 2020 Q2 | 11.49 Million CNY | 6069.48% |
| 2020 Q3 | 41.41 Million CNY | 260.42% |
| 2020 Q4 | 49.46 Million CNY | 19.44% |
| 2019 FY | 74.44 Million CNY | 113.93% |
| 2019 Q4 | 25.43 Million CNY | 0.0% |
| 2018 FY | 34.79 Million CNY | 26.69% |
| 2017 FY | 27.46 Million CNY | 0.0% |